General Practice · Santa Ana, CA
NPI
1316162258
Since 2007
Specialty
General Practice
Code 208D00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1614 French St
Santa Ana, CA, 92701
Phone (714) 480-6800
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
4,852 prescriptions
Company payments, 2025
$2,445
From 13 companies
Medicare prescription drug claims, 2024
In 2024, the drug David A Sanchez prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 439 prescriptions and refills. In total David A Sanchez wrote 4,852 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Mounjaro Tirzepatide | 439 | 491 | 64 | $494K |
| Atorvastatin Calcium Generic | 277 | 645 | 84 | $1,646 |
| Farxiga Dapagliflozin Propanediol | 267 | 417 | 59 | $226K |
| Icosapent Ethyl Generic | 194 | 224 | 56 | $32K |
| Vascepa Icosapent Ethyl | 181 | 244 | 42 | $84K |
| Losartan Potassium Generic | 171 | 328 | 56 | $843 |
| Amlodipine Besylate Generic | 150 | 293 | 41 | $623 |
| Gabapentin Generic | 130 | 152 | 33 | $1,423 |
| Levothyroxine Sodium Generic | 113 | 237 | 31 | $862 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 99 | 99 | 17 | $2,123 |
| Alprazolam Generic | 97 | 97 | Under 11 | $746 |
| Benazepril Hcl Generic | 93 | 195 | 26 | $552 |
| Pregabalin Generic | 91 | 96 | 19 | $2,269 |
| Lisinopril Generic | 73 | 155 | 25 | $328 |
| Carvedilol Generic | 69 | 150 | 20 | $273 |
Brand drugs: 1,423 claims; generic drugs: 3,381 claims; opioid claims: 206.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Sanchez $2,445 ($2,445 in general payments such as food, travel and fees) from 13 companies. The largest payer was Amgen Inc. with $475.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 28 | $475 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $458 |
| Corcept Therapeutics CORT | 9 | $368 |
| Vanda Pharmaceuticals Inc. VNDA | 10 | $290 |
| Lilly USA, LLC LLY | 4 | $280 |
| Botanix SB Inc | 1 | $150 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $119 |
| Abbott Laboratories ABT | 2 | $53.16 |
| Recordati_rare_diseases_inc. | 1 | $34.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.